The Clinical Trials dossier is designed help clinical teams within pharmaceutical companies make better decisions faster. The resources in this dossier are structured like an FAQ page, addressing questions that Medical Directors, Clinical Trials Stakeholders, and other decision makers may ask. Each question is addressed with a selection of bespoke, fit-for-purpose checklists and discussion guides, timelines, links to relevant slides in The Playbook, relevant FDA guidance, publications, and other useful resources.
The objectives of these resources are to:
- Support the implementation of digital clinical measures into clinical trials by creating additional ‘how to’ resources
- Overcome common sources of fear, uncertainty, and doubt that can hold clinical trials teams back
We’ve mapped the most common FAQs in clinical trials with the order in which they should be asked and answered, and in line with clinical trials chronology. Each FAQ is also tagged with who needs to be involved in the conversation to ensure a good decision. Download here.
ICYMI Listen to the panel of experts from this Tour of Duty who collaborated to create the resources in this Dossier as they share their perspectives on the challenges and the opportunities to advance the use of digital clinical measures (excerpted from our launch event on April 30, 2021).